Siena
Italy
50
2025-03-06
41
2025-08-05
These are the the leading inventors for applications assigned to PHILOGEN S.P.A.:
PHILOGEN S.P.A. based in Siena, IT has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
COMBINATION OF AN IMMUNOCYTOKINE COMPRISING IL-12 AND A KINASE INHIBITOR
#2 | 2024-06-20ANTI-FIBROBLAST ACTIVATION PROTEIN ANTIBODIES
#3 | 2024-06-20 ✅ Patent 12,377,161 granted on 2025-08-05TNF-ALPHA IMMUNOCONJUGATE THERAPY FOR THE TREATMENT OF BRAIN TUMORS
#4 | 2023-10-05DOSAGE UNITS AND REGIMEN, USES, METHODS OR FORMULATIONS OF COMPOSITIONS COMPRISING A RECOMBINANT PROTEIN COMPRISING INTERLEUKIN-12 AND AN ANTIBODY BINDING THE EXTRA-DOMAIN B OF FIBRONECTIN
#5 | 2023-09-14TREATMENT OF PULMONARY HYPERTENSION
#6 | 2023-07-27 ✅ Patent 11,872,288 granted on 2024-01-16TNF-alpha immunoconjugate therapy for the treatment of brain tumors
#7 | 2023-06-01 ✅ Patent 12,023,381 granted on 2024-07-02Antibody compositions
#8 | 2021-12-02IL2 AND TNF MUTANT IMMUNOCONJUGATES
#9 | 2021-04-01 ✅ Patent 11,351,257 granted on 2022-06-07Antibody compositions
#10 | 2020-12-24 ✅ Patent 12,173,044 granted on 2024-12-24EDB targeting IL-12 compositions
#11 | 2019-12-12IMMUNOCYTOKINE COMBINATION THERAPY
#12 | 2019-09-19 ✅ Patent 11,274,133 granted on 2022-03-15IL2 and TNF immunoconjugates
#13 | 2019-06-06 ✅ Patent 10,858,411 granted on 2020-12-08IL22 immunoconjugates
#14 | 2019-05-02 ✅ Patent 10,906,963 granted on 2021-02-02Non-glycosylated anti-tenascin antibody
#15 | 2019-02-28 ✅ Patent 10,647,760 granted on 2020-05-12Antibodies for treatment and diagnosis of inflammatory bowel disease
#16 | 2018-07-12 ✅ Patent 10,098,976 granted on 2018-10-16Antibodies for treatment and diagnosis
#17 | 2018-07-05 ✅ Patent 10,519,246 granted on 2019-12-31Anti-fibroblast activation protein (FAP) antibodies for treatment and diagnosis
#18 | 2018-03-22 ✅ Patent 10,308,696 granted on 2019-06-04IL2 and TNF immunoconjugates
#19 | 2018-02-15 ✅ Patent 10,239,939 granted on 2019-03-26Anti-ED-A immunoconjugates for inflammatory bowel disease
#20 | 2017-10-26 ✅ Patent 10,246,502 granted on 2019-04-02IL22 immunoconjugates
#21 | 2017-10-19 ✅ Patent 10,385,121 granted on 2019-08-20Antigen associated with rheumatoid arthritis
#22 | 2017-08-10 ✅ Patent 10,125,190 granted on 2018-11-13Anti-collagen antibodies for treatment and diagnosis
#23 | 2017-06-29 ✅ Patent 10,112,992 granted on 2018-10-30Antigens associated with endometriosis, psoriatic arthritis and psoriasis
#24 | 2016-12-29 ✅ Patent 10,202,442 granted on 2019-02-12Antigen associated with lung cancers and lymphomas
#25 | 2016-03-24 ✅ Patent 9,896,503 granted on 2018-02-20Antigen associated with the neovasculature of tumour metastases
#26 | 2016-02-11 ✅ Patent 10,344,079 granted on 2019-07-09Methods of treating a neoplastic disease
#27 | 2015-12-17 ✅ Patent 9,695,232 granted on 2017-07-04Anti-ED-A immunoconjugates for inflammatory bowel disease
#28 | 2014-11-27COMPOSITIONS AND METHODS FOR TREATMENT OF ANGIOGENESIS IN PATHOLOGICAL LESIONS
#29 | 2014-08-07 ✅ Patent 10,195,253 granted on 2019-02-05Immunocytokine combination therapy
#30 | 2014-06-19 ✅ Patent 9,580,485 granted on 2017-02-28IL-12 immunoconjugate
#31 | 2014-05-15 ✅ Patent 9,096,670 granted on 2015-08-04Antibodies of the ED-B domain of fibronectin, their construction and uses
#32 | 2014-01-07 ✅ Patent 8,623,373 granted on 2014-01-07Compositions and methods for treatment of angiogenesis in pathological lesions
#33 | 2013-10-24 ✅ Patent 9,181,347 granted on 2015-11-10Antigen associated with the neovasculature of tumour metastases
#34 | 2013-05-02Immunocytokines for Cancer Treatment in Combination with Chemotherapeutic Agents
#35 | 2013-02-14 ✅ Patent 8,481,684 granted on 2013-07-09Antigen associated with the neovasculature of tumour metastases
#36 | 2012-09-27 ✅ Patent 9,556,257 granted on 2017-01-31Antigen associated with rheumatoid arthritis
#37 | 2012-05-17 ✅ Patent 8,679,488 granted on 2014-03-25Targeting of bone marrow neovasculature
#38 | 2011-10-20 ✅ Patent 8,404,814 granted on 2013-03-26Anti-EDB antibody-targeted IL-10 cytokine for therapy of rheumatoid arthritis
#39 | 2011-10-13 ✅ Patent 8,580,267 granted on 2013-11-12Immunocytokines for tumour therapy with chemotherapeutic agents
#40 | 2011-10-13 ✅ Patent 9,527,907 granted on 2016-12-27Antigens associated with endometriosis, psoriatic arthritis and psoriasis
#41 | 2010-12-16 ✅ Patent 8,784,824 granted on 2014-07-22Compositions and methods for treatment of angiogenesis in pathological lesions
#42 | 2010-10-14 ✅ Patent 8,222,377 granted on 2012-07-17Antigen associated with rheumatoid arthritis
#43 | 2010-09-30 ✅ Patent 8,263,041 granted on 2012-09-11Antigen associated with the neovasculature of tumour metastases
#44 | 2010-05-25 ✅ Patent 7,723,269 granted on 2010-05-25Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
#45 | 2009-02-05 ✅ Patent 8,455,625 granted on 2013-06-04Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12
#46 | 2009-01-29Vascular Tumor Markers
#47 | 2008-11-06 ✅ Patent 8,703,143 granted on 2014-04-22Antibodies of the ED-B domain of fibronectin, their construction and uses
#48 | 2008-03-06 ✅ Patent 7,968,685 granted on 2011-06-28Antibodies against Tenascin-C
#49 | 2007-09-25 ✅ Patent 7,273,924 granted on 2007-09-25Antibodies to the ED-B domain of fibronectin, their construction and uses
#50 | 2006-09-19 ✅ Patent 7,109,301 granted on 2006-09-19Tenascin-C isoform as marker for neoplasias
Also check out PHILOGEN S.P.A.'s (Siena, Italy) applicant profile with 30 patent applications submitted.
20555 ⎘